Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,888
datasets available to search
ShareScore release 0.9.0
Dataset results
2,888 results for “Alzheimer's disease”
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
ClinicalTrials.gov study NCT02580305. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
ClinicalTrials.gov study NCT03518073. IPD Sharing: YES. Countries: 3. Publications: 1.
Cholinergic Deep Brain Stimulation for Alzheimer's Disease
ClinicalTrials.gov study NCT05882344. IPD Sharing: YES. Countries: 1. Publications: 7.
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease
ClinicalTrials.gov study NCT03352557. IPD Sharing: YES. Countries: 9. Publications: 1.
Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease
ClinicalTrials.gov study NCT02222181. IPD Sharing: NO. Countries: 1. Publications: 3.
Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
ClinicalTrials.gov study NCT00594568. IPD Sharing: Not stated. Countries: 19. Publications: 4.
Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients
ClinicalTrials.gov study NCT04388254. IPD Sharing: NO. Countries: 2. Publications: 4.
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
ClinicalTrials.gov study NCT02477800. IPD Sharing: Not stated. Countries: 14. Publications: 3.
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
ClinicalTrials.gov study NCT02670083. IPD Sharing: Not stated. Countries: 30. Publications: 4.
Information About Alzheimer's Disease for Latinos in New York City
ClinicalTrials.gov study NCT04471779. IPD Sharing: YES. Countries: 1. Publications: 17.
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
ClinicalTrials.gov study NCT04520698. IPD Sharing: YES. Countries: 1. Publications: 3.
Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease
ClinicalTrials.gov study NCT03402659. IPD Sharing: NO. Countries: 5. Publications: 2.
Alzheimer's Disease: Potential Benefit of Isoflavones
ClinicalTrials.gov study NCT00205179. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease
ClinicalTrials.gov study NCT01767311. IPD Sharing: Not stated. Countries: 11. Publications: 5.
Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients
ClinicalTrials.gov study NCT02551809. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
ClinicalTrials.gov study NCT02783573. IPD Sharing: YES. Countries: 18. Publications: 2.
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
ClinicalTrials.gov study NCT02615002. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT01369225. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
ClinicalTrials.gov study NCT00506415. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00348140. IPD Sharing: YES. Countries: 22. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.